Nello Mainolfi - 08 Aug 2023 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role: Chief Executive Officer, Director
Signature: /s/ Bruce N. Jacobs, Attorney-in-Fact
Issuer symbol: KYMR
Transactions as of: 08 Aug 2023
Net transactions value: +$24,960
Form type: 4
Filing time: 08 Aug 2023, 16:30:52 UTC
Previous filing: 03 Mar 2023
Next filing: 06 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KYMR	Common Stock	Options Exercise	$24,960	+12,000	+2.1%	$2.08^*	586,570	08 Aug 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	-12,000	-84%	$0.000000	2,368	08 Aug 2023	Common Stock	12,000	$2.08	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This number includes 870 shares acquired under the Registrant's employee stock purchase plan on May 31, 2023.
F2	The shares underlying this stock option vested in forty-eight (48) equal monthly installments following the vesting commencement date of February 7, 2019, subject to the reporting person's continued employment through each vesting date.